Wave Life Sciences
WVE
60 hedge funds and large institutions have $220M invested in Wave Life Sciences in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 27 reducing their positions, and 32 closing their positions.
4,767% more call options, than puts
Call options by funds: $146K | Put options by funds: $3K
131% more capital invested
Capital invested by funds: $95.3M → $220M (+$125M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.23% less ownership
Funds ownership: 78.39% → 78.16% (-0.23%)
27% less funds holding
Funds holding: 82 → 60 (-22)
59% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 27
63% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$18.1M |
| 2 |
6CM
683 Capital Management
New York
|
+$13.6M |
| 3 |
MCM
M28 Capital Management
Stamford,
Connecticut
|
+$4.68M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$4.42M |
| 5 |
MC
Maverick Capital
Dallas,
Texas
|
+$4.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.08M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.83M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.64M |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.08M |
| 5 |
SG Americas Securities
New York
|
-$972K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Group One Trading
Chicago,
Illinois
| – | -$30.6K | -15,931 | Closed |
|
77
State Board of Administration of Florida Retirement System
Tallahassee,
Florida
| – | -$31K | -15,277 | Closed |
|
78
ProShare Advisors
Bethesda,
Maryland
| – | -$28K | -14,386 | Closed |
|
79
Russell Investments Group
London,
United Kingdom
| – | -$24K | -12,534 | Closed |
|
80
Barclays
London,
United Kingdom
| – | -$14K | -7,381 | Closed |
|
|
AB
81
Amalgamated Bank
New York
| – | -$14K | -7,218 | Closed |
|
82
US Bancorp
Minneapolis,
Minnesota
| – | -$9K | -4,532 | Closed |
|
83
Legal & General Group
London,
United Kingdom
| – | -$9K | -4,355 | Closed |
|
|
AIP
84
Ameritas Investment Partners
Lincoln,
Nebraska
| – | -$4K | -2,106 | Closed |
|
85
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$2K | -1,101 | Closed |
|
|
ACM
86
Aquatic Capital Management
Chicago,
Illinois
| – | -$2K | -1,100 | Closed |
|
87
Osaic Holdings
Scottsdale,
Arizona
| – | -$1K | -500 | Closed |
|
88
Simplex Trading
Chicago,
Illinois
| – | -$15 | -8 | Closed |
|
|
CS
89
Credit Suisse
Zurich,
Switzerland
| – | +$46 | +24 | New |
|
WVE Hedge Fund Activity: Q2 2022 in Review
60 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q2 2022, worth a combined $220M — up 131% from $95.3M a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of WVE and 12 opened new positions — a net loss of 20 holders — while 27 trimmed existing stakes and 11 added.
The largest buyer was RA Capital Management, adding an estimated $18.1M. The largest seller was BlackRock, cutting an estimated $3.08M.
- 60 institutional investors held Wave Life Sciences (WVE) as of Q2 2022, down from 82 in Q1 2022.
- Funds reported $220M of Wave Life Sciences stock for Q2 2022, up 131% quarter-over-quarter.
- 12 funds opened new Wave Life Sciences positions in Q2 2022 and 32 closed out, a net change of -20 holders.
- The largest Wave Life Sciences buyer in Q2 2022 was RA Capital Management, an estimated $18.1M added.
- The largest Wave Life Sciences seller in Q2 2022 was BlackRock, an estimated $3.08M sold.
Based on aggregated 13F filings for Q2 2022.